KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $3.75 $7.64 Friday, 26th Apr 2024 FATE stock ended at $3.80. This is 1.81% less than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 5.47% from a day low at $3.75 to a day high of $3.95.
90 days $3.75 $8.83
52 weeks $1.63 $8.83

Historical Fate Therapeutics prices

Date Open High Low Close Volume
Mar 23, 2023 $5.33 $5.36 $5.08 $5.23 2 140 273
Mar 22, 2023 $5.42 $5.48 $5.13 $5.15 2 764 351
Mar 21, 2023 $5.61 $5.61 $5.38 $5.42 1 678 146
Mar 20, 2023 $5.48 $5.65 $5.19 $5.56 3 031 577
Mar 17, 2023 $5.57 $5.57 $5.39 $5.54 17 426 874
Mar 16, 2023 $5.53 $5.66 $5.32 $5.57 1 792 772
Mar 15, 2023 $5.42 $5.60 $5.36 $5.56 2 630 155
Mar 14, 2023 $5.40 $5.50 $5.27 $5.48 2 968 198
Mar 13, 2023 $4.91 $5.44 $4.79 $5.39 4 071 260
Mar 10, 2023 $5.32 $5.35 $4.78 $4.88 5 625 523
Mar 09, 2023 $5.62 $5.67 $5.33 $5.35 1 982 853
Mar 08, 2023 $5.65 $5.83 $5.55 $5.62 1 798 319
Mar 07, 2023 $5.82 $5.92 $5.66 $5.68 1 749 201
Mar 06, 2023 $6.18 $6.25 $5.79 $5.82 2 319 259
Mar 03, 2023 $6.11 $6.28 $5.96 $6.11 1 521 595
Mar 02, 2023 $6.10 $6.21 $5.83 $6.09 2 911 647
Mar 01, 2023 $6.16 $6.99 $6.09 $6.09 3 126 473
Feb 28, 2023 $6.01 $6.31 $6.00 $6.12 3 363 166
Feb 27, 2023 $5.89 $6.06 $5.81 $6.01 3 189 090
Feb 24, 2023 $6.02 $6.14 $5.72 $5.79 3 870 677
Feb 23, 2023 $6.37 $6.46 $5.83 $6.10 2 051 608
Feb 22, 2023 $6.06 $6.39 $6.02 $6.31 1 813 401
Feb 21, 2023 $6.40 $6.47 $5.86 $6.03 2 479 887
Feb 17, 2023 $6.18 $6.56 $6.07 $6.55 2 934 628
Feb 16, 2023 $6.30 $6.39 $6.12 $6.14 1 753 977
Click to get the best stock tips daily for free!

About Fate Therapeutics

Fate Therapeutics Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell lymphoma and chronic lymphocytic leukemia; FT538 to treat AML and multiple myeloma; FT576 to treat mul... FATE Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT